Phase IIb study of KUR 211 in patients with diabetic foot ulcers

Trial Profile

Phase IIb study of KUR 211 in patients with diabetic foot ulcers

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 08 Mar 2016

At a glance

  • Drugs KUR 211 (Primary)
  • Indications Diabetic foot ulcer
  • Focus Therapeutic Use
  • Sponsors Kuros Biosciences
  • Most Recent Events

    • 08 Mar 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top